UNODC Report Warns of Rising Synthetic Drug Use in Afghanistan
A new UNODC report says drug use in Afghanistan remains dominated by traditional substances, while synthetic and pharmaceutical drug misuse is rising, straining households nationwide.
A new UNODC report released on February 1, 2026, finds drug use in Afghanistan remains dominated by cannabis and opium, while synthetic drugs and misused pharmaceuticals are steadily increasing.
Survey results show cannabis and opium remain most common, while methamphetamine and so-called “Tablet K” are increasingly reported in communities across the country.
Researchers say poverty, unemployment, illness, and psychological distress are major drivers of drug dependence, with drug costs often exceeding a worker’s daily income.
The report also highlights health risks, noting many drug users lack access to treatment and sterile equipment, while women face greater barriers to receiving care.
UNODC and UNDP officials say the findings will guide future policies focused on treatment, harm reduction, and addressing economic conditions fueling drug use.
Previous UNODC surveys showed rising injection drug use and widespread needle sharing, raising concerns about disease transmission and gaps in harm-reduction coverage.
Facility mapping also revealed treatment services remain limited, unevenly distributed, and mostly focused on men, leaving women and rural populations underserved.
Experts stress that tackling drug use requires linking treatment with mental health support, employment opportunities, and social protection to reduce dependence pressures.
UN agencies also call for expanding voluntary, rights-based treatment and reducing stigma so more people seek help without fear of discrimination.
The report concludes that prevention, accessible treatment, and economic support remain essential to curb drug misuse and protect Afghanistan’s communities from long-term social and health damage.
The post UNODC Report Warns of Rising Synthetic Drug Use in Afghanistan appeared first on Khaama Press.